Thursday, February 22, 2018

US FDA News: Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease

Prescribers advised to consider using other antibiotics in patients with heart disease.
Read more: Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease